share_log

醫思健康:內幕消息 正面盈利預告

EC HEALTHCARE: INSIDE INFORMATION POSITIVE PROFIT ALERT

HKEX ·  Nov 19 18:45

Summary by Futu AI

醫思健康(EC Healthcare)於2024年11月19日發布正面盈利預告,預計截至2024年9月30日止六個月的財務業績將顯示顯著增長。根據初步未經審計的綜合管理帳目,公司預計息稅折舊及攤銷前盈利將較去年同期增加不少於7%,而純利則預計將增加不少於60%。增益主要來自於新設立服務點的營運效率提升、總部成本優化以及淨利息支出減少。公司提醒股東及潛在投資者,這些初步數據未經審核,且最終業績可能受其他因素影響。醫思健康計劃於2024年11月28日公佈詳細的中期業績。
醫思健康(EC Healthcare)於2024年11月19日發布正面盈利預告,預計截至2024年9月30日止六個月的財務業績將顯示顯著增長。根據初步未經審計的綜合管理帳目,公司預計息稅折舊及攤銷前盈利將較去年同期增加不少於7%,而純利則預計將增加不少於60%。增益主要來自於新設立服務點的營運效率提升、總部成本優化以及淨利息支出減少。公司提醒股東及潛在投資者,這些初步數據未經審核,且最終業績可能受其他因素影響。醫思健康計劃於2024年11月28日公佈詳細的中期業績。
ec healthcare (EC Healthcare) announced a positive profit forecast on November 19, 2024, expecting significant growth in financial performance for the six months ending on September 30, 2024. Based on preliminary unaudited consolidated management accounts, the company expects profit before interest, tax, depreciation, and amortization to increase by no less than 7% compared to the same period last year, while net profit is expected to increase by no less than 60%. The gains primarily stem from operational efficiency improvements at newly established service points, headquarters cost optimization, and reduced net interest expenses. The company reminds shareholders and potential investors that these preliminary data are unaudited, and final performance may be affected by other factors. EC Healthcare plans to announce detailed mid-year performance on November 28, 2024.
ec healthcare (EC Healthcare) announced a positive profit forecast on November 19, 2024, expecting significant growth in financial performance for the six months ending on September 30, 2024. Based on preliminary unaudited consolidated management accounts, the company expects profit before interest, tax, depreciation, and amortization to increase by no less than 7% compared to the same period last year, while net profit is expected to increase by no less than 60%. The gains primarily stem from operational efficiency improvements at newly established service points, headquarters cost optimization, and reduced net interest expenses. The company reminds shareholders and potential investors that these preliminary data are unaudited, and final performance may be affected by other factors. EC Healthcare plans to announce detailed mid-year performance on November 28, 2024.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.